Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 388.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 12.50 (3.243%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Resolutions of the Board of Directors: Dividends

3 Apr 2020 07:00

RNS Number : 6590I
Banco Santander S.A.
02 April 2020
 

 

Banco Santander, S.A. (the "Bank" or "Santander"), in accordance with the provisions of the Spanish capital markets regulations, announces the following:

INSIDE INFORMATION

On 23 March the Bank communicated its decision to cancel the interim dividend for fiscal year 2020 and to postpone any decision on the 2020 dividends until there is more visibility on the full impact of this crisis.

This decision was taken to ensure the Bank has as much flexibility as possible to allow it to maximize lending and support businesses and individuals affected by the coronavirus (COVID-19) pandemic, despite the fact that the Bank meets the capital requirements to maintain its current dividend policy (i.e. a 40-50% payout ratio) and is comfortable with its capital buffers over regulatory requirements.

Last Friday, 27 March 2020, the European Central Bank (ECB) requested through a recommendation issued to all European banks under its supervision to preserve capital by cancelling the payment of dividends against 2019 and 2020 results with precisely the same objectives the Bank outlined with its aforementioned actions.

This recommendation explicitly said that those entities that had already called their general shareholders meeting, as was the case for the Bank, should change their dividend proposal to comply with the recommendation. In addition, on 31 March a Royal Decree-Law 11/2020 was approved in Spain expressly providing for and enabling the withdrawal of the proposed application of 2019 earnings from general shareholders meetings which have already been convened. This new rule thus explicitly allows the Bank to follow the ECB recommendation.

Today, taking into consideration the ECB recommendation and in line with the Bank's mission to help people and businesses prosper, the board of the Bank has decided to cancel the payment of the final dividend against 2019 results and the dividend policy for 2020 approving for that purpose the following resolutions:

1. To revise its dividend policy, including for the application of the 2020 results, in the sense that the board's intention is now not to propose any dividend distribution to shareholders until there is more visibility of the effects of the COVID-19 crisis and the 2020 results are known;

2. To withdraw from the agenda of the ordinary general shareholders meeting of the Bank that will be held tomorrow 3 April 2020 on second call the proposals under points Two (Application of 2019 results) and Seven A (Capital increase against reserves to implement the scrip dividend that was contemplated in connection with the above mentioned application of results). This withdrawal does not affect the Bank's annual accounts (nor, therefore, requires them to be restated) nor the approval of the points under point One (Annual accounts and corporate management) nor under any other points of the agenda, as provided for by Royal Decree-Law 11/2020 and the joint communication issued by the Spanish National Securities Commission and the Spanish Registrars Society on 26 March 2020;

3. To withdraw the resolutions of the board passed on 28 January and 27 February through which the above mentioned proposed application of 2019 results was put forward for approval by the ordinary general shareholders meeting; and 

4. To expressly establish that the board's intention is that the new proposed application of 2019 results, which will be submitted for approval by a new general shareholders meeting to be held within the legal term prescribed for holding the ordinary general shareholders meeting (and which is expected to take place in October 2020), will be to apply the 2019 results in full (excluding the amount of the interim dividend paid in November 2019 which totalled 1,661,811,458.20 euros) to voluntary reserves, without prejudice to the possibility of it being then resolved to propose to such general shareholders meeting a distribution following a reassessment of the situation once the uncertainties caused by the COVID-19 crisis disappear.

 

Boadilla del Monte (Madrid), 2 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUPUQACUPUGMP
Date   Source Headline
24th Apr 20237:00 amRNSEnd of the Programme & 19-21 April Transactions
19th Apr 202311:22 amRNSBuyback programme: transactions 12 - 18 April
18th Apr 202311:26 amRNSNotice of First Quarter 2023 Results
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts
28th Feb 20237:00 amRNSExecution of 2022 shareholder remuneration policy
24th Feb 20237:00 amRNSDirector/PDMR Shareholding
21st Feb 202310:58 amRNSInvestor Day meeting announcement
17th Feb 20231:33 pmRNSDirector/PDMR Shareholding
7th Feb 202311:24 amRNSTender Offer
2nd Feb 20237:00 amRNS2022 Financial report & Earnings presentation
2nd Feb 20237:00 amRNS2022 Results - Press release
1st Feb 202311:06 amRNSEnd of the Programme & 26 -31 Jan Transactions
31st Jan 20233:22 pmRNSTotal Voting Rights
26th Jan 202311:08 amRNSNotice of 2022 Results
26th Jan 202311:03 amRNSBuyback programme: transactions 19 - 25 January
19th Jan 202311:14 amRNSBuyback programme: transactions 12 - 18 January
12th Jan 202311:29 amRNSBuyback programme: transactions 5 - 11 January
5th Jan 202311:14 amRNSBuyback programme: transactions 29 Dec- 4 Jan
30th Dec 202212:18 pmRNSTotal Voting Rights
29th Dec 202211:06 amRNSBuyback programme: transactions 21- 28 December
28th Dec 20227:00 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 202211:33 amRNSTotal early redemption of mortgage covered bonds
22nd Dec 202210:17 amRNSSREP Capital Requirements 2023
21st Dec 20224:59 pmRNSDirector/PDMR Shareholding
21st Dec 202211:14 amRNSBuyback programme: transactions 12- 20 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.